Gene · 125061
AFMID: arylformamidase
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. AFMID: arylformamidase. Genes, record 125061. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/125061
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q63HM1 | Kynurenine formamidase | 303 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents10
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2025062604 A | 2025-04-14 | 6575 | Q63HM1 | Espacenet |
| US 11564998 B2 | 2023-01-31 | 7177 | Q63HM1 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 6575 | Q63HM1 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 109546 | Q63HM1 | Espacenet |
| US 10463751 B2 | 2019-11-05 | 7177 | Q63HM1 | Espacenet |
| JP 2019158777 A | 2019-09-19 | 1094 | Q63HM1 | Espacenet |
| JP 2018023373 A | 2018-02-15 | 29904 | Q63HM1 | Espacenet |
| US 9572897 B2 | 2017-02-21 | 7177 | Q63HM1 | Espacenet |
| US 9303079 B2 | 2016-04-05 | 7177 | Q63HM1 | Espacenet |
| JP 2015519040 A | 2015-07-09 | 29904 | Q63HM1 | Espacenet |
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants663
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | AFMID papers | Newest fiscal year |
|---|---|---|---|
| P20GM103430 | Rhode Island IDeA Network of Biomedical Research Excellence | 4 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 4 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| T32ES007028 | Training Program in Environmental Toxicology | 3 | 2025 |
| P30CA022453 | CANCER CENTER SUPPORT GRANT | 2 | 2025 |
| P30CA033572 | Cancer Center Support Grant | 2 | 2025 |
| P30CA044579 | University of Virginia Cancer Center Support Grant | 2 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 2 | 2025 |
| R01CA248857 | Interdisciplinary Epidemiologic Consortium to Investigate T-cell Response in Colorectal Cancer | 2 | 2025 |
| R01GM015792 | Structure and Relations of Protein and Nucleic Acids | 2 | 2025 |
1 to 10 of 663Source NIH's project files
See all 663 nih grantsPapers1,612
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A kynurenine immune-metabolic subtype of depression defined by childhood maltreatment and IDO2: Evidence from multi-omics profiling. | Psychol Med | 2026 | 42803521 | PubTator, text mining | PubMed |
| Integrated placental microarray and single-cell transcriptomic analysis prioritizes Trp-Kyn-NAD+ axis-related candidate markers in pre-eclampsia. | Reprod Fertil Dev | 2026 | 42675787 | PubTator, text mining | PubMed |
| Stage-Dependent Changes in Kynurenine Pathway Enzyme Expression Suggest Immune-Related Involvement in Bladder Cancer Progression. | Int J Urol | 2026 | 42095396 | PubTator, text mining | PubMed |
| The human branchpoint-interacting stem-loop sequence and structure regulates U2 snRNA expression, branchpoint recognition, and the transcriptome. | Nucleic Acids Res | 2026 | 41885209 | PubTator, text mining | PubMed |
| An Adaptive Fault-Tolerant Federated Kalman Filter for a Multi-Sensor Integrated Navigation System. | Sensors (Basel) | 2026 | 41755299 | PubTator, text mining | PubMed |
| Altered Tryptophan-Kynurenine Pathway and Low-Grade Inflammation in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Insights from LC-MS/MS-Based Metabolite Profiling. | Int J Tryptophan Res | 2026 | 41743582 | PubTator, text mining | PubMed |
| Tryptophan metabolism reprogramming potentially contributes to the prothrombotic milieu in mice and humans with SARS-CoV-2. | Blood Vessel Thromb Hemost | 2026 | 41743170 | PubTator, text mining | PubMed |
| Characterizing the tuberculosis and type 2 diabetes mellitus comorbidity in a South African cohort using untargeted GCxGC-TOFMS metabolomics. | Metabolomics | 2026 | 41553570 | PubTator, text mining | PubMed |
| <p>KMO downregulation promotes hepatocellular carcinoma growth via 3‑HAA‑mediated mitochondrial mass and function imbalances</p>. | Int J Oncol | 2026 | 41543194 | PubTator, text mining | PubMed |
| Integrated Transcriptomic and Metabolomic Analysis Revealed That Tryptophan Metabolism-Related Metabolites Are Biomarkers of Trastuzumab Resistance. | J Clin Lab Anal | 2025 | 41189333 | PubTator, text mining | PubMed |
1 to 10 of 1,612
See all 1,612 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/125061
GET https://conductscience.org/api/genes/v1/125061/grants?page=2